Contracts Finder · Tender
Hereditary Angioedema
A public procurement published by NHS England via Contracts Finder.
- —
- Award value
- £74.5m
- Tender value
- 0
- Suppliers
- 0
- Awards
- 1
- Notices
- Tender
- Stage
Overview
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be nor more than 48 months. Please refer to the offer documents for the list of purchasing points.
Key details
- Buyer
- NHS England
- Source
- Contracts Finder
- Lifecycle stage
- Tender
- Status
- active
- CPV classification
- 33600000 — Pharmaceutical products
- Currency
- GBP
- Total award value
- —
- Tender value
- £74,500,000
- First published
- 9 Feb 2022
- Last updated
- 9 Feb 2022
Notice timeline
Every published notice in this procurement's lifecycle.
Frameworks & programmes
More from NHS England
FAQs about this procurement
Who is the buyer for "Hereditary Angioedema"?
Hereditary Angioedema is a UK public-sector procurement published by NHS England via Contracts Finder.
Has "Hereditary Angioedema" been awarded?
No award has been recorded yet. The current lifecycle stage is "Tender".
What is "Hereditary Angioedema" worth?
The reported tender value is £74,500,000.
When was "Hereditary Angioedema" published?
It was first published on 9 Feb 2022 and last updated on 9 Feb 2022, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable